Dr Reddys Laboratories RDY
NYSE RDY
$14.90 +0.38 (+2.62%)
At close: Nov 6, 2026 · 4:00 PM EST

Dr Reddys Laboratories (RDY) Long-Term Investments (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) posted Long-Term Investments of $655.36 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 3.0% from $675.34 million a year earlier and down 22.6% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Long-Term Investments (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Dr Reddys Laboratories' Long-Term Investments came in at $60 million, up 7.1% from FY2025.

  • Annual Long-Term Investments shows a five-year compound annual growth rate of 5.5% (FY2021 to FY2026).
  • In prior fiscal years, Dr Reddys Laboratories' Long-Term Investments was $56 million in FY2025 (+12.0%), $50 million in FY2024 (-12.3%), $57 million in FY2023 (unchanged) and $57 million in FY2022 (+23.9%).
  • Quarterly Long-Term Investments has run from a low of $50.32 million in fiscal Q4 2024 to a high of $1.09 billion in fiscal Q1 2025 over five years.
  • On a year-over-year basis, Long-Term Investments increased in five of the last eight quarters, with growth averaging 0.7%.
  • The strongest year-over-year quarter for Long-Term Investments in the past five years was fiscal Q2 2024, with growth of 172.6%; the weakest was fiscal Q1 2026, with a decline of 30.9%.
  • According to Business Quant data, Long-Term Investments for the three prior fiscal quarters was $847.17 million (Q1 2027), $60.12 million (Q4 2026) and $763.45 million (Q3 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,224.11 Bn 1,197.72 Bn 20.46 Bn 4.01 Bn
2 Johnson & Johnson 665.34 Bn 585.20 Bn 17.30 Bn -
3 AbbVie 515.72 Bn 483.73 Bn 13.12 Bn 387.00 Mn
4 Merck 362.64 Bn 325.58 Bn 13.19 Bn 1.60 Bn
5 Novartis Ag 315.51 Bn 288.75 Bn - 63.00 Mn
6 Astrazeneca 289.26 Bn 263.15 Bn 13.26 Bn 268.00 Mn
7 Amgen 249.20 Bn 200.85 Bn 7.58 Bn -
8 Gilead Sciences 207.48 Bn 182.59 Bn 6.73 Bn -
9 Pfizer 167.49 Bn 114.85 Bn 12.56 Bn 1.45 Bn
10 Dr Reddys Laboratories 12.40 Bn 11.74 Bn 472.93 Mn 655.36 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 655.36 Mn
Jun 30, 2026 847.17 Mn
Mar 31, 2026 60.12 Mn
Dec 31, 2025 763.45 Mn
Sep 30, 2025 675.34 Mn
Jun 30, 2025 750.86 Mn
Mar 31, 2025 56.24 Mn
Dec 31, 2024 596.43 Mn
Sep 30, 2024 618.09 Mn
Jun 30, 2024 1.09 Bn
Mar 31, 2024 50.32 Mn
Dec 31, 2023 839.96 Mn
Sep 30, 2023 676.08 Mn
Jun 30, 2023 657.13 Mn
Mar 31, 2023 57.27 Mn
Dec 31, 2022 530.03 Mn
Sep 30, 2022 248.03 Mn
Jun 30, 2022 369.73 Mn
Mar 31, 2022 56.94 Mn
Dec 31, 2021 209.32 Mn
API Access

Dr Reddys Laboratories Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=RDY&period=max&api_key=YOUR_API_KEY